EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Anticancer effect of the antipsychotic agent penfluridol on epithelial ovarian cancer

Won-Ji Kim iD, Ji-Yoon Ryu iD, Chi-Son Chang iD, Young-Jae Cho iD, Jung-Joo Choi iD, Jae Ryoung Hwang iD, Ju-Yeon Choi iD, Jeong-Won Lee iD

Journal of Gynecologic Oncology · 2025

DOI: 10.3802/jgo.2025.36.e28 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gynecologic Oncology, 2025. Verfasst von Won-Ji Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Antipsychotic Agents, Penfluridol, Carcinoma, Ovarian Epithelial. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NRF, Commercialization Promotion Agency for R&D Outcomes, SMC-SKKU Future Convergence Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Chemoresistant-epithelial ovarian cancer (EOC) has a poor prognosis, prompting the search for new therapeutic drugs. The diphenylbutylpiperidine (DPBP) class of antipsychotic drugs used in schizophrenia has shown anticancer effects. This study aimed to investigate the preclinical efficacy of penfluridol, fluspirilene, and pimozide (DPBP) using in vitro and in vivo models of EOC. METHODS: Human EOC cell lines A2780, HeyA8, SKOV3ip1, A2780-CP20, HeyA8-MDR, and SKOV3-TR were treated with penfluridol, fluspirilene, and pimozide, and cell proliferation, apoptosis, and migration were assessed. The preclinical efficacy of DPBP was also investigated using in vivo mouse models, including cell lines and patient-derived xenografts (PDX) of EOC. RESULTS: DPBP drugs significantly decreased cell proliferation in chemosensitive (A2780, HeyA8, and SKOV3ip1) and chemoresistant (A2780-CP20, HeyA8-MDR, and SKOV3-TR) cell lines. Among these drugs, penfluridol exerted a relatively stronger cytotoxic effect on all cell lines. Penfluridol significantly increased apoptosis and inhibited migration of EOC cells. In the cell line xenograft mouse model with HeyA8, the penfluridol group showed significantly decreased tumor weight compared with the control group. In the paclitaxel-resistant model with HeyA8-MDR, the penfluridol group had significantly decreased tumor weight compared with the paclitaxel or control groups. Penfluridol exerted anticancer effects on the PDX model. CONCLUSION: Penfluridol exerted significant anticancer effects on EOC cells and xenograft models, including PDX. Thus, penfluridol therapy, as a drug repurposing strategy, might be a potential therapeutic for EOCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsAntipsychotic AgentsPenfluridolCarcinoma, Ovarian EpithelialAntineoplastic AgentsFemaleHumansAnimalsCell Line, TumorMiceApoptosisCell ProliferationXenograft Model Antitumor AssaysCell MovementPimozideMice, NudeDrug Resistance, Neoplasm

Stichwörter der Autor:innen

Cell Line XenograftDiphenylbutylDrug RepurposingEpithelial Ovarian CancerPatient-Derived XenograftPenfluridol

Substanzen

Antipsychotic AgentsPenfluridolPimozideAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Research Institute for Future Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Department of Obstetrics and Gynecology, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, Gwangmyeong, Korea.
  • Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University School of Medicine, Seoul, Korea. garden.lee@samsung.com.

ORCID-Profile: Won-Ji Kim, Ji-Yoon Ryu, Chi-Son Chang, Young-Jae Cho, Jung-Joo Choi, Jae Ryoung Hwang, Ju-Yeon Choi, Jeong-Won Lee

Förderung

  • NRF
  • Commercialization Promotion Agency for R&D Outcomes
  • SMC-SKKU Future Convergence Research Program
  • National Research Foundation of Korea

Zitieren

APA

Kim, W. J., Ryu, J. Y., Chang, C. S., Cho, Y. J., Choi, J. J., Hwang, J. R., Choi, J. Y., & Lee, J. W. (2025). Anticancer effect of the antipsychotic agent penfluridol on epithelial ovarian cancer. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2025.36.e28

Vancouver

Kim WJ, Ryu JY, Chang CS, Cho YJ, Choi JJ, Hwang JR, et al. Anticancer effect of the antipsychotic agent penfluridol on epithelial ovarian cancer. Journal of Gynecologic Oncology. 2025. doi:10.3802/jgo.2025.36.e28

BibTeX
@article{Kim2025,
  author = {Kim, Won-Ji and Ryu, Ji-Yoon and Chang, Chi-Son and Cho, Young-Jae and Choi, Jung-Joo and Hwang, Jae Ryoung and Choi, Ju-Yeon and Lee, Jeong-Won},
  title = {Anticancer effect of the antipsychotic agent penfluridol on epithelial ovarian cancer},
  journal = {Journal of Gynecologic Oncology},
  year = {2025},
  doi = {10.3802/jgo.2025.36.e28}
}
Kostenlos starten →